Placebo (n = 28) | Budesonide (n = 26) | % difference (95% CI) | χ2 | p Value | |
---|---|---|---|---|---|
Median (range) age (weeks) | 10 (1–38) | 11 (3–42) | — | — | 0.70 |
Boys (n) | 14 | 20 | 26.9 (1.1 to 52.7) | 3.12 | 0.08 |
Family history of atopy (n) | 19 | 15 | 10.2 (−15.6 to 36.0) | 0.24 | 0.62 |
Number with household smokers | 21 | 17 | 9.6 (−14.8 to 34.0) | 0.23 | 0.63 |
Median (range) days in hospital | 4 (1–14) | 3 (1–13) | — | — | 0.75 |
RSV positive on NPA (n) | 211-150 | 14† | 8.95 (−12.5 to 30.4) | 0.13 | 0.72 |
Requiring oxygen (n) | 10 | 11 | 6.59 (−19.4 to 32.6) | 0.05 | 0.83 |
Requiring NG feeds (n) | 15 | 13 | 3.57 (−23.1 to 30.3) | 0.07 | 0.79 |
↵1-150 n = 23; †n = 17.
RSV, respiratory syncitial virus; NPA, nasopharyngeal aspirate; NG, nasogastric.